Insufficient scRNA-seq data for expression of IL23A at single-cell level.
Insufficient scRNA-seq data for expression of IL23A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 72.94 | 573 / 578 | 91% | 10.04 | 1054 / 1155 |
pancreas | 97% | 31.88 | 318 / 328 | 93% | 8.79 | 165 / 178 |
thymus | 100% | 39.45 | 653 / 653 | 86% | 5.57 | 520 / 605 |
uterus | 94% | 19.08 | 159 / 170 | 89% | 11.02 | 408 / 459 |
bladder | 90% | 51.86 | 19 / 21 | 91% | 13.26 | 458 / 504 |
intestine | 92% | 40.45 | 884 / 966 | 89% | 10.70 | 471 / 527 |
ovary | 97% | 25.54 | 175 / 180 | 79% | 5.22 | 340 / 430 |
esophagus | 87% | 75.74 | 1263 / 1445 | 87% | 8.15 | 160 / 183 |
stomach | 92% | 22.36 | 329 / 359 | 81% | 7.72 | 231 / 286 |
breast | 98% | 31.74 | 451 / 459 | 74% | 3.54 | 829 / 1118 |
skin | 99% | 38.04 | 1786 / 1809 | 60% | 2.39 | 284 / 472 |
prostate | 98% | 39.97 | 240 / 245 | 55% | 1.69 | 278 / 502 |
kidney | 98% | 39.09 | 87 / 89 | 49% | 1.94 | 443 / 901 |
liver | 100% | 46.58 | 225 / 226 | 33% | 1.97 | 133 / 406 |
adrenal gland | 99% | 30.17 | 255 / 258 | 29% | 0.93 | 67 / 230 |
brain | 92% | 21.42 | 2435 / 2642 | 28% | 0.79 | 196 / 705 |
spleen | 100% | 125.05 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 32.75 | 1166 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 116.81 | 871 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 17.14 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 10.14 | 26 / 29 |
blood vessel | 80% | 15.57 | 1062 / 1335 | 0% | 0 | 0 / 0 |
heart | 62% | 10.15 | 532 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 33% | 0.86 | 26 / 80 |
muscle | 24% | 2.98 | 192 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0042104 | Biological process | positive regulation of activated T cell proliferation |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0051135 | Biological process | positive regulation of NK T cell activation |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0010536 | Biological process | positive regulation of activation of Janus kinase activity |
GO_0006954 | Biological process | inflammatory response |
GO_0042098 | Biological process | T cell proliferation |
GO_0043382 | Biological process | positive regulation of memory T cell differentiation |
GO_0045087 | Biological process | innate immune response |
GO_2000318 | Biological process | positive regulation of T-helper 17 type immune response |
GO_0032819 | Biological process | positive regulation of natural killer cell proliferation |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0007165 | Biological process | signal transduction |
GO_0051607 | Biological process | defense response to virus |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0034105 | Biological process | positive regulation of tissue remodeling |
GO_0032693 | Biological process | negative regulation of interleukin-10 production |
GO_0001916 | Biological process | positive regulation of T cell mediated cytotoxicity |
GO_0045672 | Biological process | positive regulation of osteoclast differentiation |
GO_0048771 | Biological process | tissue remodeling |
GO_0032725 | Biological process | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO_0051142 | Biological process | positive regulation of NK T cell proliferation |
GO_0032816 | Biological process | positive regulation of natural killer cell activation |
GO_0090023 | Biological process | positive regulation of neutrophil chemotaxis |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0002827 | Biological process | positive regulation of T-helper 1 type immune response |
GO_2000330 | Biological process | positive regulation of T-helper 17 cell lineage commitment |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0042509 | Biological process | regulation of tyrosine phosphorylation of STAT protein |
GO_0032740 | Biological process | positive regulation of interleukin-17 production |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005576 | Cellular component | extracellular region |
GO_0070743 | Cellular component | interleukin-23 complex |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0045519 | Molecular function | interleukin-23 receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL23A |
Protein name | Interleukin-23 subunit alpha (IL-23 subunit alpha) (IL-23-A) (Interleukin-23 subunit p19) (IL-23p19) |
Synonyms | SGRF UNQ2498/PRO5798 |
Description | FUNCTION: Associates with IL12B to form the pro-inflammatory cytokine IL-23 that plays different roles in innate and adaptive immunity . Released by antigen-presenting cells such as dendritic cells or macrophages, binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R to activate JAK2 and TYK2 which then phosphorylate the receptor to form a docking site leading to the phosphorylation of STAT3 and STAT4 . This process leads to activation of several pathways including p38 MAPK or NF-kappa-B and promotes the production of pro-inflammatory cytokines such as interleukin-17A/IL17A . In turn, participates in the early and effective intracellular bacterial clearance . Promotes the expansion and survival of T-helper 17 cells, a CD4-positive helper T-cell subset that produces IL-17, as well as other IL-17-producing cells . . |
Accessions | ENST00000228534.6 Q9NPF7 |